Remove 2019 Remove Healthcare Remove Hypertension Remove Provider
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Race, racism, and racial inequality have tangible impacts on people’s livelihoods, much less their experiences in the healthcare system. doi:10.7326/0003-4819-150-9-200905050-00006 African American Study of Kidney Disease and Hypertension (AASK): AASK Clinical Trial in the NIDDK Repository: [link] Lewis J, Agodoa L, Cheek D, et al.

Clinic 52
article thumbnail

FDA Publishes Two Draft Guidances Addressing Non-prescription Drugs Labels

FDA Law Blog

Interestingly, in the 2019 proposal for sunscreen labeling, FDA proposed to require a size at least one quarter the size of the most prominent printed matter). Interestingly, it provides information for manufacturers who want to include (voluntarily) the phosphorus level in the drug product.

article thumbnail

Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model

BMJ

In the United Kingdom (UK), primary care practitioners are the first-line clinicians which most patients encounter, providing initial assessment and treatment of a wide variety of conditions. Over one billion prescriptions per year are signed in the UK by these general practitioners (GPs) in primary care.